Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?

To: Jim Lamb who wrote (4360)	7/15/1998 1:19:00 PM
From: Anthony Wong	Read Replies (1) \| Respond to of 9523

Pfizer to Meet With Japan After Death of Viagra User (Repeat) Bloomberg News July 15, 1998, 12:33 p.m. ET (Repeats to note Pfizer comment added in 3rd paragraph.) Tokyo, July 15 (Bloomberg) -- Pfizer Inc., the second largest U.S. drugmaker, said it will meet with Japanese health officials to discuss ways to educate the public there about the impotence pill, Viagra, after the death of a Japanese Viagra user was reported. The Japanese Ministry of Heath and Welfare said a man in his 60s died earlier this month after taking Viagra. The man also was taking a heart medicine, nitroglycerin, that Pfizer has warned against combining with Viagra. Viagra hasn't yet been approved in Japan, said Andrew McCormick, a Pfizer spokesman. Pfizer is in the last stage of testing needed to apply for regulatory approval of Viagra in Japan as well as in China, he said. In Japan, consumers are allowed to import the drug for individual use, health officials said. Other men purchase the drug on the Internet. Pfizer fell 1 7/8 to 116 5/8 in midday trading. Early sales of Viagra boosted Pfizer to a record 121 3/4 on April 21, letting it briefly pass rival Merck & Co. as the most valuable U.S. company. The drug had $411 million in sales in its first three months on the market, helping boost Pfizer's second-quarter profit 38 percent to $628 million. The Japanese ministry said it hasn't determined if there's a link between the man's death and the drug. The man, who had diabetes, took one tablet of Viagra, which he obtained from a friend. He had sexual intercourse and died three and a half hours after taking the drug, the ministry said. Pfizer, based in New York, has laboratories in Connecticut and England. It also makes the antidepressant Zoloft and Bain de Soleil sunscreens. --Kerry Dooley in the Princeton newsrom and Junko Fujita in the More News: PFE